| abstract |
THE INVENTION CONCERNS THE PHARMACEUTICAL INDUSTRY. IT IS SUBJECT TO (-) - D- ISOMERS OF COMPOUNDS OF GENERAL FORMULA: (CF DRAWING IN BOPI) OR R REPRESENTS AN ALIPHATIC C5 RADICAL POSSIBLY SUBSTITUTE, X REPRESENTS AN ACID RADICAL AND SPECIALLY A PHOSPHONIC ACID RADICAL, D SULFONIC ACID, BORONIC ACID OR TETRAZOLE, ETA AND B INDEPENDENTLY REPRESENT A LIPOPHILIC RADICAL, AS ARE THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND BIOPRECURERS. THESE COMPOUNDS FIND THEIR PREFERRED APPLICATION IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS. |